123 related articles for article (PubMed ID: 14640541)
1. A method for designing conformationally restricted analogues based on allylic strain: synthesis of a novel class of noncompetitive NMDA receptor antagonists having the acrylamide structure.
Ohmori Y; Yamashita A; Tsujita R; Yamamoto T; Taniuchi K; Matsuda A; Shuto S
J Med Chem; 2003 Dec; 46(25):5326-33. PubMed ID: 14640541
[TBL] [Abstract][Full Text] [Related]
2. (E)-3-(2-(N-phenylcarbamoyl)vinyl)pyrrole-2-carboxylic acid derivatives. A novel class of glycine site antagonists.
Balsamini C; Bedini A; Diamantini G; Spadoni G; Tontini A; Tarzia G; Di Fabio R; Feriani A; Reggiani A; Tedesco G; Valigi R
J Med Chem; 1998 Mar; 41(6):808-20. PubMed ID: 9526557
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological activity of conformationally restricted analogs of milnacipran: (1S,2R)-1-phenyl-2-[(S)-1-aminopropyl]-N,N-diethylcyclopropanecarboxami de, an efficient noncompetitive N-methyl-D-aspartic acid receptor antagonist.
Shuto S; Ono S; Hase Y; Ueno Y; Noguchi T; Yoshii K; Matsuda A
J Med Chem; 1996 Nov; 39(24):4844-52. PubMed ID: 8941398
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and structure-activity relationships of 6,7-benzomorphan derivatives as antagonists of the NMDA receptor-channel complex.
Grauert M; Bechtel WD; Ensinger HA; Merz H; Carter AJ
J Med Chem; 1997 Aug; 40(18):2922-30. PubMed ID: 9288174
[TBL] [Abstract][Full Text] [Related]
5. Stereocontrolled synthesis of cyclopropanol amino acids from allylic sulfones: conformationally restricted building blocks.
Díez D; Garcia P; Marcos IS; Garrido NM; Basabe P; Broughton HB; Urones JG
Org Lett; 2003 Oct; 5(20):3687-90. PubMed ID: 14507205
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and structure/NMDA receptor affinity relationships of 1-substituted tetrahydro-3-benzazepines.
Krull O; Wünsch B
Bioorg Med Chem; 2004 Mar; 12(6):1439-51. PubMed ID: 15018917
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, preliminary evaluation and molecular modeling studies of new, conformationally constrained analogues of the competitive NMDA receptor antagonist 4-(phosphonomethyl)-2-piperidinecarboxylic acid (CGS 19755).
Pellicciari R; Marinozzi M; Natalini B; Costantino G; Lankin DC; Snyder JP; Monahan JB
Farmaco; 1997; 52(6-7):477-86. PubMed ID: 9490080
[TBL] [Abstract][Full Text] [Related]
8. Structure-activity relationships of cyclic peptide-based chemokine receptor CXCR4 antagonists: disclosing the importance of side-chain and backbone functionalities.
Ueda S; Oishi S; Wang ZX; Araki T; Tamamura H; Cluzeau J; Ohno H; Kusano S; Nakashima H; Trent JO; Peiper SC; Fujii N
J Med Chem; 2007 Jan; 50(2):192-8. PubMed ID: 17228861
[TBL] [Abstract][Full Text] [Related]
9. N-(6,7-dichloro-2,3-dioxo-1,2,3,4-tetrahydroquinoxalin-5-yl)-N-alkylsulfonamides as peripherally restricted N-methyl-D-aspartate receptor antagonists for the treatment of pain.
Deur C; Agrawal AK; Baum H; Booth J; Bove S; Brieland J; Bunker A; Connolly C; Cornicelli J; Dumin J; Finzel B; Gan X; Guppy S; Kamilar G; Kilgore K; Lee P; Loi CM; Lou Z; Morris M; Philippe L; Przybranowski S; Riley F; Samas B; Sanchez B; Tecle H; Wang Z; Welch K; Wilson M; Yates K
Bioorg Med Chem Lett; 2007 Aug; 17(16):4599-603. PubMed ID: 17562362
[TBL] [Abstract][Full Text] [Related]
10. Stereochemical diversity-oriented conformational restriction strategy. Development of potent histamine H3 and/or H4 receptor antagonists with an imidazolylcyclopropane structure.
Watanabe M; Kazuta Y; Hayashi H; Yamada S; Matsuda A; Shuto S
J Med Chem; 2006 Sep; 49(18):5587-96. PubMed ID: 16942032
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, binding affinity at glutamic acid receptors, neuroprotective effects, and molecular modeling investigation of novel dihydroisoxazole amino acids.
Conti P; De Amici M; Grazioso G; Roda G; Pinto A; Hansen KB; Nielsen B; Madsen U; Bräuner-Osborne H; Egebjerg J; Vestri V; Pellegrini-Giampietro DE; Sibille P; Acher FC; De Micheli C
J Med Chem; 2005 Oct; 48(20):6315-25. PubMed ID: 16190758
[TBL] [Abstract][Full Text] [Related]
12. Elucidation of the bioactive conformation of the N-substituted trans-3,4-dimethyl-4-(3-hydroxyphenyl)piperidine class of mu-opioid receptor antagonists.
Le Bourdonnec B; Goodman AJ; Michaut M; Ye HF; Graczyk TM; Belanger S; Herbertz T; Yap GP; DeHaven RN; Dolle RE
J Med Chem; 2006 Dec; 49(25):7278-89. PubMed ID: 17149858
[TBL] [Abstract][Full Text] [Related]
13. Tricyclic indole-2-carboxylic acids: highly in vivo active and selective antagonists for the glycine binding site of the NMDA receptor.
Katayama S; Ae N; Kodo T; Masumoto S; Hourai S; Tamamura C; Tanaka H; Nagata R
J Med Chem; 2003 Feb; 46(5):691-701. PubMed ID: 12593650
[TBL] [Abstract][Full Text] [Related]
14. 1-Substituted pyrazolo[1,5-c]quinazolines as novel Gly/NMDA receptor antagonists: synthesis, biological evaluation, and molecular modeling study.
Varano F; Catarzi D; Colotta V; Calabri FR; Lenzi O; Filacchioni G; Galli A; Costagli C; Deflorian F; Moro S
Bioorg Med Chem; 2005 Oct; 13(19):5536-49. PubMed ID: 16087341
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of derivatives of (1S,2R)-1-phenyl-2-[(S)-1-aminopropyl]-N,N-diethylcyclopropanecarboxamide (PPDC) modified at the 1-aromatic moiety as novel NMDA receptor antagonists: the aromatic group is essential for the activity.
Kazuta Y; Tsujita R; Yamashita K; Uchino S; Kohsaka S; Matsuda A; Shuto S
Bioorg Med Chem; 2002 Dec; 10(12):3829-48. PubMed ID: 12413836
[TBL] [Abstract][Full Text] [Related]
16. Novel isothiourea derivatives as potent neuroprotectors and cognition enhancers: synthesis, biological and physicochemical properties.
Perlovich GL; Proshin AN; Volkova TV; Kurkov SV; Grigoriev VV; Petrova LN; Bachurin SO
J Med Chem; 2009 Apr; 52(7):1845-52. PubMed ID: 19338354
[TBL] [Abstract][Full Text] [Related]
17. CoMFA, synthesis, and pharmacological evaluation of (E)-3-(2-carboxy-2-arylvinyl)-4,6-dichloro-1H-indole-2-carboxylic acids: 3-[2-(3-aminophenyl)-2-carboxyvinyl]-4,6-dichloro-1H-indole-2-carboxylic acid, a potent selective glycine-site NMDA receptor antagonist.
Baron BM; Cregge RJ; Farr RA; Friedrich D; Gross RS; Harrison BL; Janowick DA; Matthews D; McCloskey TC; Meikrantz S; Nyce PL; Vaz R; Metz WA
J Med Chem; 2005 Feb; 48(4):995-1018. PubMed ID: 15715469
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological activity of conformationally restricted analogues of milnacipran: (1S, 2R)-1-phenyl-2-[(R)-1-amino-2-propynyl]-N,N- diethylcyclopropanecarboxamide is a novel class of NMDA receptor channel blocker.
Shuto S; Ono S; Imoto H; Yoshii K; Matsuda A
J Med Chem; 1998 Aug; 41(18):3507-14. PubMed ID: 9719604
[TBL] [Abstract][Full Text] [Related]
19. (1S,2R)-1-Phenyl-2-[(S)-1-aminopropyl]-N,N-diethylcyclopropanecarboxamide (PPDC), a new class of NMDA-receptor antagonist: molecular design by a novel conformational restriction strategy.
Shuto S; Yoshii K; Matsuda A
Jpn J Pharmacol; 2001 Mar; 85(3):207-13. PubMed ID: 11325012
[TBL] [Abstract][Full Text] [Related]
20. Catalytic asymmetric conjugate addition and allylic alkylation with Grignard reagents.
Harutyunyan SR; den Hartog T; Geurts K; Minnaard AJ; Feringa BL
Chem Rev; 2008 Aug; 108(8):2824-52. PubMed ID: 18698733
[No Abstract] [Full Text] [Related]
[Next] [New Search]
